Osteoarthritis, the most common type of arthritis, is a leading cause of disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement. Medicines for Osteoarthritis Pain are available as pills, syrups, creams or lotions, or they are injected into a joint, including analgesics, nonsteroidal anti-inflammatory drugs, corticosteroids, hyaluronic acid, and phase III drugs.
Market Analysis and Insights: Global Osteoarthritis Drugs Market
The global Osteoarthritis Drugs market size is projected to reach US$ 7675.4 million by 2027, from US$ 5893.9 million in 2020, at a CAGR of 4.5% during 2021-2027.
Global Osteoarthritis Drugs Scope and Segment
The global Osteoarthritis Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Osteoarthritis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Oral
Injection
External
By the end users/application, this report covers the following segments
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
The report provides a list of all the key players in the Osteoarthritis Drugs market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developmentss to remain competitive in the market.
The Osteoarthritis Drugs key manufacturers in this market include:
Johnson & Johnson
Pfizer
Eli Lilly
Abbott
GlaxoSmithKline
Sanofi
Flexion Therapeutics
Market Analysis and Insights: Global Osteoarthritis Drugs Market
The global Osteoarthritis Drugs market size is projected to reach US$ 7675.4 million by 2027, from US$ 5893.9 million in 2020, at a CAGR of 4.5% during 2021-2027.
Global Osteoarthritis Drugs Scope and Segment
The global Osteoarthritis Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Osteoarthritis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Oral
Injection
External
By the end users/application, this report covers the following segments
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
The report provides a list of all the key players in the Osteoarthritis Drugs market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developmentss to remain competitive in the market.
The Osteoarthritis Drugs key manufacturers in this market include:
Johnson & Johnson
Pfizer
Eli Lilly
Abbott
GlaxoSmithKline
Sanofi
Flexion Therapeutics
1 Osteoarthritis Drugs Market Overview
1.1 Osteoarthritis Drugs Product Overview
1.2 Osteoarthritis Drugs Market Segment by Type
1.2.1 Oral
1.2.2 Injection
1.2.3 External
1.3 Global Osteoarthritis Drugs Market Size by Type
1.3.1 Global Osteoarthritis Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global Osteoarthritis Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Osteoarthritis Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Osteoarthritis Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Osteoarthritis Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Osteoarthritis Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Osteoarthritis Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Osteoarthritis Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Osteoarthritis Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Osteoarthritis Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe Osteoarthritis Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Osteoarthritis Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Osteoarthritis Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Osteoarthritis Drugs Sales Breakdown by Type (2016-2021)
2 Global Osteoarthritis Drugs Market Competition by Company
2.1 Global Top Players by Osteoarthritis Drugs Sales (2016-2021)
2.2 Global Top Players by Osteoarthritis Drugs Revenue (2016-2021)
2.3 Global Top Players Osteoarthritis Drugs Price (2016-2021)
2.4 Global Top Manufacturers Osteoarthritis Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Osteoarthritis Drugs Market Competitive Situation and Trends
2.5.1 Osteoarthritis Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Osteoarthritis Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Osteoarthritis Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into Osteoarthritis Drugs Market
2.8 Key Manufacturers Osteoarthritis Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Osteoarthritis Drugs Status and Outlook by Region
3.1 Global Osteoarthritis Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Osteoarthritis Drugs Historic Market Size by Region
3.2.1 Global Osteoarthritis Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global Osteoarthritis Drugs Sales in Value by Region (2016-2021)
3.2.3 Global Osteoarthritis Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Osteoarthritis Drugs Forecasted Market Size by Region
3.3.1 Global Osteoarthritis Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global Osteoarthritis Drugs Sales in Value by Region (2022-2027)
3.3.3 Global Osteoarthritis Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Osteoarthritis Drugs by Application
4.1 Osteoarthritis Drugs Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Osteoarthritis Drugs Market Size by Application
4.2.1 Global Osteoarthritis Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global Osteoarthritis Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Osteoarthritis Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Osteoarthritis Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Osteoarthritis Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Osteoarthritis Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Osteoarthritis Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Osteoarthritis Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Osteoarthritis Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Osteoarthritis Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe Osteoarthritis Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Osteoarthritis Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Osteoarthritis Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Osteoarthritis Drugs Sales Breakdown by Application (2016-2021)
5 North America Osteoarthritis Drugs by Country
5.1 North America Osteoarthritis Drugs Historic Market Size by Country
5.1.1 North America Osteoarthritis Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America Osteoarthritis Drugs Sales in Value by Country (2016-2021)
5.2 North America Osteoarthritis Drugs Forecasted Market Size by Country
5.2.1 North America Osteoarthritis Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America Osteoarthritis Drugs Sales in Value by Country (2022-2027)
6 Europe Osteoarthritis Drugs by Country
6.1 Europe Osteoarthritis Drugs Historic Market Size by Country
6.1.1 Europe Osteoarthritis Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe Osteoarthritis Drugs Sales in Value by Country (2016-2021)
6.2 Europe Osteoarthritis Drugs Forecasted Market Size by Country
6.2.1 Europe Osteoarthritis Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe Osteoarthritis Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific Osteoarthritis Drugs by Region
7.1 Asia-Pacific Osteoarthritis Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Osteoarthritis Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Osteoarthritis Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Osteoarthritis Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Osteoarthritis Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Osteoarthritis Drugs Sales in Value by Region (2022-2027)
8 Latin America Osteoarthritis Drugs by Country
8.1 Latin America Osteoarthritis Drugs Historic Market Size by Country
8.1.1 Latin America Osteoarthritis Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America Osteoarthritis Drugs Sales in Value by Country (2016-2021)
8.2 Latin America Osteoarthritis Drugs Forecasted Market Size by Country
8.2.1 Latin America Osteoarthritis Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America Osteoarthritis Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa Osteoarthritis Drugs by Country
9.1 Middle East and Africa Osteoarthritis Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Osteoarthritis Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Osteoarthritis Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Osteoarthritis Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Osteoarthritis Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Osteoarthritis Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Osteoarthritis Drugs Business
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Corporation Information
10.1.2 Johnson & Johnson Introduction and Business Overview
10.1.3 Johnson & Johnson Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Johnson & Johnson Osteoarthritis Drugs Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 Pfizer
10.2.1 Pfizer Corporation Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Johnson & Johnson Osteoarthritis Drugs Products Offered
10.2.5 Pfizer Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Corporation Information
10.3.2 Eli Lilly Introduction and Business Overview
10.3.3 Eli Lilly Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Eli Lilly Osteoarthritis Drugs Products Offered
10.3.5 Eli Lilly Recent Development
10.4 Abbott
10.4.1 Abbott Corporation Information
10.4.2 Abbott Introduction and Business Overview
10.4.3 Abbott Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Abbott Osteoarthritis Drugs Products Offered
10.4.5 Abbott Recent Development
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Corporation Information
10.5.2 GlaxoSmithKline Introduction and Business Overview
10.5.3 GlaxoSmithKline Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 GlaxoSmithKline Osteoarthritis Drugs Products Offered
10.5.5 GlaxoSmithKline Recent Development
10.6 Sanofi
10.6.1 Sanofi Corporation Information
10.6.2 Sanofi Introduction and Business Overview
10.6.3 Sanofi Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Sanofi Osteoarthritis Drugs Products Offered
10.6.5 Sanofi Recent Development
10.7 Flexion Therapeutics
10.7.1 Flexion Therapeutics Corporation Information
10.7.2 Flexion Therapeutics Introduction and Business Overview
10.7.3 Flexion Therapeutics Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Flexion Therapeutics Osteoarthritis Drugs Products Offered
10.7.5 Flexion Therapeutics Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Osteoarthritis Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Osteoarthritis Drugs Industrial Chain Analysis
11.4 Osteoarthritis Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Osteoarthritis Drugs Distributors
12.3 Osteoarthritis Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Osteoarthritis Drugs Product Overview
1.2 Osteoarthritis Drugs Market Segment by Type
1.2.1 Oral
1.2.2 Injection
1.2.3 External
1.3 Global Osteoarthritis Drugs Market Size by Type
1.3.1 Global Osteoarthritis Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global Osteoarthritis Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Osteoarthritis Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Osteoarthritis Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Osteoarthritis Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Osteoarthritis Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Osteoarthritis Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Osteoarthritis Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Osteoarthritis Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Osteoarthritis Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe Osteoarthritis Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Osteoarthritis Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Osteoarthritis Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Osteoarthritis Drugs Sales Breakdown by Type (2016-2021)
2 Global Osteoarthritis Drugs Market Competition by Company
2.1 Global Top Players by Osteoarthritis Drugs Sales (2016-2021)
2.2 Global Top Players by Osteoarthritis Drugs Revenue (2016-2021)
2.3 Global Top Players Osteoarthritis Drugs Price (2016-2021)
2.4 Global Top Manufacturers Osteoarthritis Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Osteoarthritis Drugs Market Competitive Situation and Trends
2.5.1 Osteoarthritis Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Osteoarthritis Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Osteoarthritis Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into Osteoarthritis Drugs Market
2.8 Key Manufacturers Osteoarthritis Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Osteoarthritis Drugs Status and Outlook by Region
3.1 Global Osteoarthritis Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Osteoarthritis Drugs Historic Market Size by Region
3.2.1 Global Osteoarthritis Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global Osteoarthritis Drugs Sales in Value by Region (2016-2021)
3.2.3 Global Osteoarthritis Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Osteoarthritis Drugs Forecasted Market Size by Region
3.3.1 Global Osteoarthritis Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global Osteoarthritis Drugs Sales in Value by Region (2022-2027)
3.3.3 Global Osteoarthritis Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Osteoarthritis Drugs by Application
4.1 Osteoarthritis Drugs Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Osteoarthritis Drugs Market Size by Application
4.2.1 Global Osteoarthritis Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global Osteoarthritis Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Osteoarthritis Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Osteoarthritis Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Osteoarthritis Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Osteoarthritis Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Osteoarthritis Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Osteoarthritis Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Osteoarthritis Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Osteoarthritis Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe Osteoarthritis Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Osteoarthritis Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Osteoarthritis Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Osteoarthritis Drugs Sales Breakdown by Application (2016-2021)
5 North America Osteoarthritis Drugs by Country
5.1 North America Osteoarthritis Drugs Historic Market Size by Country
5.1.1 North America Osteoarthritis Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America Osteoarthritis Drugs Sales in Value by Country (2016-2021)
5.2 North America Osteoarthritis Drugs Forecasted Market Size by Country
5.2.1 North America Osteoarthritis Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America Osteoarthritis Drugs Sales in Value by Country (2022-2027)
6 Europe Osteoarthritis Drugs by Country
6.1 Europe Osteoarthritis Drugs Historic Market Size by Country
6.1.1 Europe Osteoarthritis Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe Osteoarthritis Drugs Sales in Value by Country (2016-2021)
6.2 Europe Osteoarthritis Drugs Forecasted Market Size by Country
6.2.1 Europe Osteoarthritis Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe Osteoarthritis Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific Osteoarthritis Drugs by Region
7.1 Asia-Pacific Osteoarthritis Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Osteoarthritis Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Osteoarthritis Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Osteoarthritis Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Osteoarthritis Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Osteoarthritis Drugs Sales in Value by Region (2022-2027)
8 Latin America Osteoarthritis Drugs by Country
8.1 Latin America Osteoarthritis Drugs Historic Market Size by Country
8.1.1 Latin America Osteoarthritis Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America Osteoarthritis Drugs Sales in Value by Country (2016-2021)
8.2 Latin America Osteoarthritis Drugs Forecasted Market Size by Country
8.2.1 Latin America Osteoarthritis Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America Osteoarthritis Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa Osteoarthritis Drugs by Country
9.1 Middle East and Africa Osteoarthritis Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Osteoarthritis Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Osteoarthritis Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Osteoarthritis Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Osteoarthritis Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Osteoarthritis Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Osteoarthritis Drugs Business
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Corporation Information
10.1.2 Johnson & Johnson Introduction and Business Overview
10.1.3 Johnson & Johnson Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Johnson & Johnson Osteoarthritis Drugs Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 Pfizer
10.2.1 Pfizer Corporation Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Johnson & Johnson Osteoarthritis Drugs Products Offered
10.2.5 Pfizer Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Corporation Information
10.3.2 Eli Lilly Introduction and Business Overview
10.3.3 Eli Lilly Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Eli Lilly Osteoarthritis Drugs Products Offered
10.3.5 Eli Lilly Recent Development
10.4 Abbott
10.4.1 Abbott Corporation Information
10.4.2 Abbott Introduction and Business Overview
10.4.3 Abbott Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Abbott Osteoarthritis Drugs Products Offered
10.4.5 Abbott Recent Development
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Corporation Information
10.5.2 GlaxoSmithKline Introduction and Business Overview
10.5.3 GlaxoSmithKline Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 GlaxoSmithKline Osteoarthritis Drugs Products Offered
10.5.5 GlaxoSmithKline Recent Development
10.6 Sanofi
10.6.1 Sanofi Corporation Information
10.6.2 Sanofi Introduction and Business Overview
10.6.3 Sanofi Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Sanofi Osteoarthritis Drugs Products Offered
10.6.5 Sanofi Recent Development
10.7 Flexion Therapeutics
10.7.1 Flexion Therapeutics Corporation Information
10.7.2 Flexion Therapeutics Introduction and Business Overview
10.7.3 Flexion Therapeutics Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Flexion Therapeutics Osteoarthritis Drugs Products Offered
10.7.5 Flexion Therapeutics Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Osteoarthritis Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Osteoarthritis Drugs Industrial Chain Analysis
11.4 Osteoarthritis Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Osteoarthritis Drugs Distributors
12.3 Osteoarthritis Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
